|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
13 June 2016 |
|
Main ID: |
NCT02393781 |
|
Date of registration:
|
13/03/2015 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock
AdrenOSS |
|
Scientific title:
|
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock. The AdrenOSS Study. |
|
Date of first enrolment:
|
June 2015 |
|
Target sample size:
|
596 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02393781 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Belgium
|
France
|
Germany
|
Italy
|
Netherlands
| | | |
|
Contacts
|
|
Name:
|
Pierre François Laterre, Pr |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Clinique Universitaire St Luc, Belgique |
|
|
Name:
|
Alexandre Mebazaa, Pr |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hôpital Lariboisière, France |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age >18 years
- Patients admitted in intensive care unit for severe sepsis or septic shock according
to international, standardized criteria,transferred from another intensive care unit
less than 24 hours after the primary admission, or being treated with vasopressors
for less than 24 hours in the prior ICU
- Signed Consent form
Exclusion Criteria:
- Age < 18 years
- Severe sepsis or septic shock patients transferred from another intensive care unit
later than 24 hours after the primary admission or being treated with vasopressors
for more than 24 hours in the prior ICU
- Pregnant women
- Vegetative coma
- Participation in an interventional clinical trial in the preceding month
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Septic Shock
|
|
Severe Sepsis
|
|
Primary Outcome(s)
|
|
rate of all-cause mortality
[Time Frame: Day 28.]
|
|
Secondary ID(s)
|
|
2014-A01906-41
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|